Search

everythinglearnresearchcommunity

for

Search:↓

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Men and premenopausal women in Korea show different patterns in iron and vitamin D levels, with no clear pattern for postmenopausal women.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

Hair loss is common in IBD patients, and some medications may lower the risk.